Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
Liaison en sciences médicales - Rheumatologie - Ontario Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
Chef de Produit Snr en Dermatologie H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Marketing Oct 25, 2024
Chef de produit rhumatologie H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Marketing Oct 25, 2024
Administrateur Outils et Canaux Digitaux H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Technology Transformation Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
Transformation Strategy Manager Jr Santo Amaro Brazil International Innovative Medicines Market Access Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Yantai (Shandong Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Ningbo (Zhejiang Province) China International Innovative Medicines Sales Oct 24, 2024
Senior Global Program Regulatory Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 24, 2024
Senior Global Program Regulatory Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 24, 2024
Global Program Regulatory Manager - Life Cycle Management London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 24, 2024
Global Program Regulatory Director London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 24, 2024
Global Program Regulatory Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 24, 2024
BPA Manager - Global Process Owner Hyderabad (Office) India Finance Corporate Audit & Finance Oct 24, 2024
Qualification Expert (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Oct 24, 2024
Procurement Analyst Prague Czech Republic Operations Innovative Medicines Technical Operations Oct 24, 2024
Senior Manager Vendor Management Hyderabad (Office) India People & Organization CTS Procurement Oct 24, 2024
Data Steward Hyderabad (Office) India Operations CTS Marketing Oct 24, 2024
Director Product Tracking Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 24, 2024
Senior Scientist - Discovery & Translational Pharmacology (80-100%*) Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Oct 24, 2024
Buyer (with Italian) Prague Czech Republic Operations CTS Procurement Oct 24, 2024
Labormitarbeiter - visuelle Inspektion (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
Labortechniker / QC Analyst I (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
Associate Director AI & Automation Lead London (The Westworks) United Kingdom Development Innovative Medicines Data and Digital Oct 24, 2024
Associate Director, Data Engineering Lead London (The Westworks) United Kingdom Development Innovative Medicines Data and Digital Oct 24, 2024
Talent Acquisition Business Partner Home Worker United Kingdom People & Organization CTS Human Resources Oct 24, 2024
Regional Procurement Category Manager Fleet Prague Czech Republic Operations CTS Procurement Oct 24, 2024
Vendor Management & Governance Manager Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Oct 24, 2024
Global Category Manager, Clinical Hyderabad (Office) India Operations CTS Procurement Oct 24, 2024
Cluster Procurement Category Manager, Fleet Prague Czech Republic Operations CTS Procurement Oct 24, 2024
Director of Commercial Policy Communications and Media Relations, Europe Basel (City) Switzerland Corporate Affairs CTS Communications & Public Affairs Oct 24, 2024
QA Operations Manager Warsaw Poland Operations Innovative Medicines Quality Oct 24, 2024
H2R Services Specialist Hyderabad (Office) India People & Organization CTS Human Resources Oct 24, 2024
Associate Medical Director-RLT Remote Position (USA) USA US Innovative Medicines Research & Development Oct 24, 2024
Human Resources Expert (Temporary 12 moths) INSURGENTES Mexico People & Organization CTS Human Resources Oct 24, 2024
Neurology Territory Account Specialist – Nashville / Knoxville – Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 24, 2024
CTS Business Planning Analysis Manager INSURGENTES Mexico Finance CTS Audit & Finance Oct 24, 2024
Technician, Science & Technology - Analytical Development East Hanover USA Development Innovative Medicines Research & Development Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Ningbo (Zhejiang Province) China International Innovative Medicines Sales Oct 24, 2024
Specialist QA Operations Selangor Malaysia Operations Innovative Medicines Quality Oct 24, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only